Principal Technologies Inc. logo

Principal Technologies Inc. (JO7)

Market Closed
12 Jun, 20:00
XFRA XFRA
0. 25
+0
+1.626%
3.54M Market Cap
- P/E Ratio
- Div Yield
20,000 Volume
- Eps
0.25
Previous Close
Add Transaction
Day Range
0.23 0.25
Year Range
0.13 0.48
Want to track JO7 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

JO7 closed Friday higher at €0.25, an increase of 1.626% from Thursday's close, completing a monthly decrease of -10.7143% or -€0.03. Over the past 12 months, JO7 stock lost -28.9773%.
JO7 is not paying dividends to its shareholders.
The last earnings report, released on Mar 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).

JO7 Chart

People also search for

3IM
Manx Financial Group PLC
0.26
-4.4776%
PEH
Peh Wertpapier AG
30.6
+4.7945%
9L7
Tpximpact Holdings Plc
0.65
+6.5041%
SyntheticMR AB
0.04
-2.0619%
U.C.A. AG
70.5
+0.7143%

Principal Technologies Inc. (JO7) FAQ

What is the stock price today?

The current price is €0.25.

On which exchange is it traded?

Principal Technologies Inc. is listed on XFRA.

What is its stock symbol?

The ticker symbol is JO7.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 3.54M.

Has Principal Technologies Inc. ever had a stock split?

No, there has never been a stock split.

Principal Technologies Inc. Profile

Insurance Industry
Financials Sector
Mr. Gerald Trent CEO
XFRA Exchange
CA74260Q1028 ISIN
CA Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Principal Technologies Inc. is a distinguished private equity firm founded in 2018 and headquartered in Vancouver, Canada. With a strategic focus on the healthcare technology sector, the firm is dedicated to providing growth capital, investing in middle-market companies, and making direct equity investments. It leverages equity-related and secured convertible debt as its primary investment vehicles. Principal Technologies Inc. has set its sights on transforming patient care by investing in technologies and assets that promise to enhance the quality and efficiency of medical treatments, reduce costs, optimize patient pathways, and support the implementation of point-of-care technologies. By identifying innovative technologies with significant intellectual property (IP), Principal Technologies Inc. aims to make impactful investments that improve healthcare outcomes globally.

Products and Services

  • Growth Capital

    Principal Technologies Inc. provides growth capital to healthcare technology companies. This type of financial support is designed to help these companies scale their operations, invest in research and development, and expand their market reach, ultimately leading to enhanced healthcare solutions.

  • Middle Market Investments

    Focusing on middle-market investments allows Principal Technologies Inc. to tap into the potential of promising healthcare technology companies that are in the growth stage but require capital and strategic guidance to reach their full potential.

  • Direct Equity Investments

    The firm makes direct equity investments in healthcare technology companies and assets, taking a stake in these entities to play a more active role in their growth and success. This direct investment approach allows Principal Technologies Inc. to closely work with the companies it invests in, providing not only capital but also valuable industry insights and strategic advice.

  • Secured Convertible Debt

    Secured convertible debt is employed by Principal Technologies Inc. as a flexible investment instrument that offers the potential for conversion into equity of the investee company under predefined conditions. This method benefits both the firm and the investee companies by aligning their interests towards long-term success and valuation improvement.

  • Healthcare Technology Investments

    By concentrating its investments in healthcare technology, the firm seeks to support the development and implementation of innovative solutions aimed at improving patient outcomes. This includes technologies that enhance medical treatment quality and efficiency, make healthcare more cost-efficient, optimize the patient pathway, and facilitate the implementation of point-of-care technologies.

Contact Information

Address: 700 W Georgia Street, Vancouver, BC, Canada, V6C 1H2
Phone: 1 587 225 2599